A. Seferian

1.3k total citations
28 papers, 230 citations indexed

About

A. Seferian is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Seferian has authored 28 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Seferian's work include Muscle Physiology and Disorders (16 papers), Neurogenetic and Muscular Disorders Research (10 papers) and Cardiomyopathy and Myosin Studies (8 papers). A. Seferian is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Neurogenetic and Muscular Disorders Research (10 papers) and Cardiomyopathy and Myosin Studies (8 papers). A. Seferian collaborates with scholars based in France, Belgium and United Kingdom. A. Seferian's co-authors include Laurent Servais, David Vissière, Teresa Gidaro, Jean‐Yves Hogrel, M. Annoussamy, Thomas Voit, Tamara Dangouloff, Nicolas Deconinck, Mickaël Hiligsmann and Adele D’Amico and has published in prestigious journals such as PLoS ONE, Developmental Medicine & Child Neurology and Journal of Neurology.

In The Last Decade

A. Seferian

28 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Seferian France 9 153 76 55 50 39 28 230
Natalie F. Reash United States 7 214 1.4× 153 2.0× 97 1.8× 28 0.6× 46 1.2× 20 314
D Jones United Kingdom 4 225 1.5× 65 0.9× 31 0.6× 42 0.8× 31 0.8× 4 280
Chiara Marini‐Bettolo United Kingdom 9 180 1.2× 132 1.7× 80 1.5× 18 0.4× 33 0.8× 22 249
A. Nascimento Osorio Spain 8 164 1.1× 56 0.7× 31 0.6× 28 0.6× 39 1.0× 14 213
Pavel Balabanov Netherlands 8 257 1.7× 65 0.9× 17 0.3× 26 0.5× 66 1.7× 14 356
Leigh Ramos‐Platt United States 8 82 0.5× 25 0.3× 27 0.5× 19 0.4× 30 0.8× 19 174
Amy D. Harper United States 6 265 1.7× 60 0.8× 20 0.4× 33 0.7× 59 1.5× 10 317
Ravi Knight United Kingdom 6 211 1.4× 75 1.0× 46 0.8× 20 0.4× 76 1.9× 6 295
Saskia Lassche Netherlands 11 229 1.5× 64 0.8× 33 0.6× 52 1.0× 82 2.1× 22 300
Sara Napolitano Italy 6 106 0.7× 47 0.6× 21 0.4× 33 0.7× 17 0.4× 12 195

Countries citing papers authored by A. Seferian

Since Specialization
Citations

This map shows the geographic impact of A. Seferian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Seferian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Seferian more than expected).

Fields of papers citing papers by A. Seferian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Seferian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Seferian. The network helps show where A. Seferian may publish in the future.

Co-authorship network of co-authors of A. Seferian

This figure shows the co-authorship network connecting the top 25 collaborators of A. Seferian. A scholar is included among the top collaborators of A. Seferian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Seferian. A. Seferian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauché, Stéphanie, Damien Sternberg, A. Seferian, et al.. (2023). Pathogenic DPAGT1 variants in limb‐girdle congenital myasthenic syndrome (LG‐CMS) associated with tubular aggregates and ORAI1 hypoglycosylation. Neuropathology and Applied Neurobiology. 50(1). e12952–e12952. 5 indexed citations
2.
Dangouloff, Tamara, Mickaël Hiligsmann, Nicolas Deconinck, et al.. (2022). Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Developmental Medicine & Child Neurology. 65(1). 67–77. 35 indexed citations
3.
Seferian, A., Géraldine Labouret, Laurianne Coutier, et al.. (2022). Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen. Pediatric Pulmonology. 57(6). 1505–1512. 9 indexed citations
4.
Shieh, Perry B., Nancy L. Kuntz, James J. Dowling, et al.. (2022). OP018: ASPIRO gene therapy trial in X-Linked Myotubular Myopathy (XLMTM): Update on preliminary efficacy and safety findings. Genetics in Medicine. 24(3). S350–S350. 6 indexed citations
5.
Boulanger, Bruno, M. Annoussamy, A. Seferian, et al.. (2021). Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy. Orphanet Journal of Rare Diseases. 16(1). 3–3. 21 indexed citations
6.
Shieh, Perry B., James J. Dowling, Wolfgang Müller‐Felber, et al.. (2021). CLINICAL TRIAL HIGHLIGHTS. Neuromuscular Disorders. 31. S47–S47. 1 indexed citations
7.
Blaschek, Astrid, Perry B. Shieh, Nancy L. Kuntz, et al.. (2021). ASPIRO Gene Therapy Trial in X-Linked Myotubular Myopathy (XLMTM): Update on Preliminary Efficacy and Safety Findings. Neuropediatrics. 1 indexed citations
8.
Lilien, C., Harmen Reyngoudt, A. Seferian, et al.. (2021). Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy. Annals of Clinical and Translational Neurology. 8(10). 1938–1950. 10 indexed citations
9.
Hogrel, Jean‐Yves, V. Decostre, Isabelle Ledoux, et al.. (2020). Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy. Journal of Neurology. 267(7). 2022–2028. 16 indexed citations
10.
Catapano, Francesco, Joana Domingos, Valeria Ricotti, et al.. (2020). Novel Free-Circulating and Extracellular Vesicle-Derived MiRNAs Dysregulated in Duchenne Muscular Dystrophy. Epigenomics. 12(21). 1899–1915. 5 indexed citations
11.
Seferian, A., et al.. (2020). SMA - CLINICAL. Neuromuscular Disorders. 30. S72–S72. 1 indexed citations
12.
Lilien, C., et al.. (2019). Home-Based Monitor for Gait and Activity Analysis. Journal of Visualized Experiments. 16 indexed citations
13.
Lilien, C., Teresa Gidaro, A. Seferian, et al.. (2018). DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY. Neuromuscular Disorders. 28. S125–S125. 2 indexed citations
14.
Iliescu, Catrinel, A. Seferian, Svetlana Gataullina, et al.. (2017). DMD and West syndrome. Neuromuscular Disorders. 27(10). 911–913. 4 indexed citations
15.
Seferian, A., A. Moraux, Teresa Gidaro, et al.. (2017). Innovative home activity monitoring in non-ambulant patients with spinal muscular atrophy: a multicenter observational trial. Neuromuscular Disorders. 27. S225–S225. 1 indexed citations
16.
Chabanon, A., M. Annoussamy, Aurore Daron, et al.. (2017). Longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy. Neuromuscular Disorders. 27. S134–S134. 3 indexed citations
17.
Seferian, A., Edoardo Malfatti, Laurent Pelletier, et al.. (2016). Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8). Neuromuscular Disorders. 26(10). 712–716. 14 indexed citations
18.
Moing, Anne‐Gaëlle Le, A. Seferian, A. Moraux, et al.. (2016). A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment. PLoS ONE. 11(6). e0156696–e0156696. 35 indexed citations
19.
Seferian, A., C. Lilien, Thomas Voït, et al.. (2016). Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients. Neuromuscular Disorders. 26. S184–S185. 1 indexed citations
20.
Servais, Laurent, A. Seferian, Volker Straub, et al.. (2016). Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy. Neuromuscular Disorders. 26. S152–S153. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie F. Reash Breakdown of academic impact, for papers by D Jones Breakdown of academic impact, for papers by Chiara Marini‐Bettolo Breakdown of academic impact, for papers by A. Nascimento Osorio Breakdown of academic impact, for papers by Pavel Balabanov Breakdown of academic impact, for papers by Leigh Ramos‐Platt Breakdown of academic impact, for papers by Amy D. Harper Breakdown of academic impact, for papers by Ravi Knight Breakdown of academic impact, for papers by Saskia Lassche Breakdown of academic impact, for papers by Sara Napolitano
Rankless by CCL
2026